Where does Rakesh Aggarwal practice?

Rakesh Aggarwal is affiliated with SGPGI Lucknow in India.

What is Rakesh Aggarwal's H-index?

Rakesh Aggarwal has an H-index of 110, placing them in the top 1% of medical professionals worldwide.

What is Rakesh Aggarwal's medical specialty?

Rakesh Aggarwal specializes in Hepatology - Viral hepatitis research.

Is Rakesh Aggarwal verified by MDRPedia?

Yes, Rakesh Aggarwal is a verified ELITE tier physician on MDRPedia, the global authority for medical reputation.

Rakesh Aggarwal — MDRPedia

Top 1% — Elite

Rakesh Aggarwal

Hepatology - Viral hepatitis research

India

110 H-Index

1,153 Total Impact

Share or Embed Profile

Profile URL

Quick Share

Embed Style

Minimal link badge for your website

<a href="https://mdrpedia.com/doctors/rakesh-aggarwal" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:8px 16px;background:#1a1a2e;border:1px solid rgba(255,255,255,0.1);border-radius:8px;text-decoration:none;color:#fff;font-family:system-ui,sans-serif;font-size:14px;"><span style="color:#00aaff;">●</span>Rakesh Aggarwal — MDRPedia</a>

Preview:

● Rakesh Aggarwal — MDRPedia

Copied!

Overview

Rakesh Aggarwal is a hepatology - viral hepatitis research specialist with an H-index of 110 at SGPGI Lucknow (Faculty). Has been published in BMJ, JAMA Internal Medicine, JAMA. Based in India.

Biography

Rakesh Aggarwal, is a Welsh businessman and founder of the internet cosmetics retailer Escentual.com.

Affiliations & Institutions

SGPGI Lucknow

Faculty

Research Impact

5 Publications

0 Total Citations

Published In

BMJJAMALancet Gastroenterol HepatolPerspect Clin Res

Areas of Expertise

Medical Specialties

Hepatology - Viral hepatitis research

Clinical Knowledge & Procedures

Viral hepatitis

Rakesh Aggarwal

Share or Embed Profile

Overview

Biography

Affiliations & Institutions

SGPGI Lucknow

Research Impact

Published In

Key Publications

CONSORT 2025 statement: updated guideline for reporting randomised trials.

CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials.

CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials.

Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.

Study designs: Part 2 - Descriptive studies.

Areas of Expertise

Medical Specialties

Clinical Knowledge & Procedures